These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 5800740)

  • 21. Unusual primary manifestations of multiple sclerosis.
    Yetimalar Y; Seçil Y; Inceoglu AK; Eren S; Başoğlu M
    N Z Med J; 2008 Jul; 121(1277):47-59. PubMed ID: 18677330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proliferative retinal vasculitis and multiple sclerosis: a case report].
    Patte M; Rouher FN; Vernay D; Delaire JC; Bacin F
    J Fr Ophtalmol; 2003 Apr; 26(4):381-5. PubMed ID: 12843896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thymus-dependent therapeutic immunosuppression in multiple sclerosis and myasthenia].
    Lobzin VS; Golovkin VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):176-81. PubMed ID: 7072415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in survival and cause of death in Danish patients with multiple sclerosis.
    Brønnum-Hansen H; Koch-Henriksen N; Stenager E
    Brain; 2004 Apr; 127(Pt 4):844-50. PubMed ID: 14960501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Syringomyelia, a neglected differential diagnosis in multiple sclerosis. 6 cases from a specialty clinic for multiple sclerosis].
    Basedow-Rajwich B; Pöllmann W; König N
    Nervenarzt; 1995 Aug; 66(8):630-3. PubMed ID: 7566276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients.
    Racadot E; Rumbach L; Bataillard M; Galmiche J; Henlin JL; Truttmann M; Herve P; Wijdenes J
    J Autoimmun; 1993 Dec; 6(6):771-86. PubMed ID: 8155256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
    Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
    Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheumatoid arthritis and multiple sclerosis in the same patient. Two case-reports.
    Attout H; Toussirot E; Augé B; Chavot D; Wendling D
    Rev Rhum Engl Ed; 1999 Mar; 66(3):169-72. PubMed ID: 10327497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interferon therapy of multiple sclerosis].
    Jensen D
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3142-5. PubMed ID: 10522481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
    Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of visual art for stress relief: a case report of newly diagnosed multiple sclerosis.
    Kelly NA
    Explore (NY); 2009; 5(3):167-70. PubMed ID: 19409363
    [No Abstract]   [Full Text] [Related]  

  • 33. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance.
    Schyns F; Paul L; Finlay K; Ferguson C; Noble E
    Clin Rehabil; 2009 Sep; 23(9):771-81. PubMed ID: 19561035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroretinitis in patients with multiple sclerosis.
    Williams KE; Johnson LN
    Ophthalmology; 2004 Feb; 111(2):335-40; discussion 340-1. PubMed ID: 15019385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
    Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
    Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Copolymer 1 in therapy of multiple sclerosis].
    Weilbach FX; Voltz R; Hohlfeld R; Hartung HP
    Nervenarzt; 1995 Jun; 66(6):473-7. PubMed ID: 7543660
    [No Abstract]   [Full Text] [Related]  

  • 38. High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. One year follow-up.
    Bergamaschi R; Versino M; Raiola E; Citterio A; Cosi V
    Acta Neurol (Napoli); 1993 Feb; 15(1):33-43. PubMed ID: 8456594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure of multiple sclerosis patients to hyperbaric oxygen at 1.5--2 ATA. A preliminary report.
    Neubauer RA
    J Fla Med Assoc; 1980 May; 67(5):498-504. PubMed ID: 7381413
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical characteristics of multiple sclerosis in Lebanon.
    Yamout B; Barada W; Tohme RA; Mehio-Sibai A; Khalifeh R; El-Hajj T
    J Neurol Sci; 2008 Jul; 270(1-2):88-93. PubMed ID: 18367208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.